Clinical standards for drug-susceptible pulmonary TB

O W Akkerman; R Duarte; S Tiberi; H S Schaaf; C Lange; J W C Alffenaar; J Denholm; A C C Carvalho; M S Bolhuis; S Borisov; J Bruchfeld; A M Cabibbe; J A Caminero; I Carvalho; J Chakaya; R Centis; M P Dalcomo; L D'Ambrosio; M Dedicoat; K Dheda; K E Dooley; J Furin; J-M García-García; N A H van Hest; B C de Jong; X Kurhasani; A G Märtson; S Mpagama; M Munoz Torrico; E Nunes; C W M Ong; D J Palmero; R Ruslami; A M I Saktiawati; C Semuto; D R Silva; R Singla; I Solovic; S Srivastava; J E M de Steenwinkel; A Story; M G G Sturkenboom; M Tadolini; Z F Udwadia; A R Verhage; J P Zellweger; G B Migliori

doi:10.5588/ijtld.22.0228

Clinical standards for drug-susceptible pulmonary TB

O W Akkerman^*, R Duarte, S Tiberi, H S Schaaf, C Lange, J W C Alffenaar, J Denholm, A C C Carvalho, M S Bolhuis, S Borisov, J Bruchfeld, A M Cabibbe, J A Caminero, I Carvalho, J Chakaya, R Centis, M P Dalcomo, L D'Ambrosio, M Dedicoat, K DhedaK E Dooley, J Furin, J-M García-García, N A H van Hest, B C de Jong, X Kurhasani, A G Märtson, S Mpagama, M Munoz Torrico, E Nunes, C W M Ong, D J Palmero, R Ruslami, A M I Saktiawati, C Semuto, D R Silva, R Singla, I Solovic, S Srivastava, J E M de Steenwinkel, A Story, M G G Sturkenboom, M Tadolini, Z F Udwadia, A R Verhage, J P Zellweger, G B Migliori

^*Corresponding author voor dit werk

Microbes in Health and Disease (MHD)

Onderzoeksoutput: Article › Academic › peer review

30 Citaten (Scopus)

107 Downloads (Pure)

Samenvatting

BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB).

METHODS: A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants.

RESULTS: Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB.

CONCLUSION: These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB.

Originele taal-2	English
Pagina's (van-tot)	592-604
Aantal pagina's	13
Tijdschrift	International Journal of Tuberculosis and Lung Disease
Volume	26
Nummer van het tijdschrift	7
DOI's	https://doi.org/10.5588/ijtld.22.0228
Status	Published - 1-jul.-2022

Toegang tot document

10.5588/ijtld.22.0228Licentie: CC BY

Clinical standards for drug-susceptible pulmonary TBFinal publisher's version, 145 KBLicentie: CC BY

Handle.net

Permanente koppeling

Citeer dit

Akkerman, O. W., Duarte, R., Tiberi, S., Schaaf, H. S., Lange, C., Alffenaar, J. W. C., Denholm, J., Carvalho, A. C. C., Bolhuis, M. S., Borisov, S., Bruchfeld, J., Cabibbe, A. M., Caminero, J. A., Carvalho, I., Chakaya, J., Centis, R., Dalcomo, M. P., D'Ambrosio, L., Dedicoat, M., ... Migliori, G. B. (2022). Clinical standards for drug-susceptible pulmonary TB. International Journal of Tuberculosis and Lung Disease, 26(7), 592-604. https://doi.org/10.5588/ijtld.22.0228

@article{d48273b142914b0a8eb39cf15520b320,

title = "Clinical standards for drug-susceptible pulmonary TB",

abstract = "BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB).METHODS: A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants.RESULTS: Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB.CONCLUSION: These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB.",

author = "Akkerman, \{O W\} and R Duarte and S Tiberi and Schaaf, \{H S\} and C Lange and Alffenaar, \{J W C\} and J Denholm and Carvalho, \{A C C\} and Bolhuis, \{M S\} and S Borisov and J Bruchfeld and Cabibbe, \{A M\} and Caminero, \{J A\} and I Carvalho and J Chakaya and R Centis and Dalcomo, \{M P\} and L D'Ambrosio and M Dedicoat and K Dheda and Dooley, \{K E\} and J Furin and J-M Garc{\'i}a-Garc{\'i}a and \{van Hest\}, \{N A H\} and \{de Jong\}, \{B C\} and X Kurhasani and M{\"a}rtson, \{A G\} and S Mpagama and Torrico, \{M Munoz\} and E Nunes and Ong, \{C W M\} and Palmero, \{D J\} and R Ruslami and Saktiawati, \{A M I\} and C Semuto and Silva, \{D R\} and R Singla and I Solovic and S Srivastava and \{de Steenwinkel\}, \{J E M\} and A Story and Sturkenboom, \{M G G\} and M Tadolini and Udwadia, \{Z F\} and Verhage, \{A R\} and Zellweger, \{J P\} and Migliori, \{G B\}",

year = "2022",

month = jul,

day = "1",

doi = "10.5588/ijtld.22.0228",

language = "English",

volume = "26",

pages = "592--604",

journal = "International Journal of Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union against Tubercul. and Lung Dis.",

number = "7",

}

Akkerman, OW, Duarte, R, Tiberi, S, Schaaf, HS, Lange, C, Alffenaar, JWC, Denholm, J, Carvalho, ACC, Bolhuis, MS, Borisov, S, Bruchfeld, J, Cabibbe, AM, Caminero, JA, Carvalho, I, Chakaya, J, Centis, R, Dalcomo, MP, D'Ambrosio, L, Dedicoat, M, Dheda, K, Dooley, KE, Furin, J, García-García, J-M, van Hest, NAH, de Jong, BC, Kurhasani, X, Märtson, AG, Mpagama, S, Torrico, MM, Nunes, E, Ong, CWM, Palmero, DJ, Ruslami, R, Saktiawati, AMI, Semuto, C, Silva, DR, Singla, R, Solovic, I, Srivastava, S, de Steenwinkel, JEM, Story, A, Sturkenboom, MGG, Tadolini, M, Udwadia, ZF, Verhage, AR, Zellweger, JP & Migliori, GB 2022, 'Clinical standards for drug-susceptible pulmonary TB', International Journal of Tuberculosis and Lung Disease, vol. 26, nr. 7, blz. 592-604. https://doi.org/10.5588/ijtld.22.0228

TY - JOUR

T1 - Clinical standards for drug-susceptible pulmonary TB

AU - Akkerman, O W

AU - Duarte, R

AU - Tiberi, S

AU - Schaaf, H S

AU - Lange, C

AU - Alffenaar, J W C

AU - Denholm, J

AU - Carvalho, A C C

AU - Bolhuis, M S

AU - Borisov, S

AU - Bruchfeld, J

AU - Cabibbe, A M

AU - Caminero, J A

AU - Carvalho, I

AU - Chakaya, J

AU - Centis, R

AU - Dalcomo, M P

AU - D'Ambrosio, L

AU - Dedicoat, M

AU - Dheda, K

AU - Dooley, K E

AU - Furin, J

AU - García-García, J-M

AU - van Hest, N A H

AU - de Jong, B C

AU - Kurhasani, X

AU - Märtson, A G

AU - Mpagama, S

AU - Torrico, M Munoz

AU - Nunes, E

AU - Ong, C W M

AU - Palmero, D J

AU - Ruslami, R

AU - Saktiawati, A M I

AU - Semuto, C

AU - Silva, D R

AU - Singla, R

AU - Solovic, I

AU - Srivastava, S

AU - de Steenwinkel, J E M

AU - Story, A

AU - Sturkenboom, M G G

AU - Tadolini, M

AU - Udwadia, Z F

AU - Verhage, A R

AU - Zellweger, J P

AU - Migliori, G B

PY - 2022/7/1

Y1 - 2022/7/1

N2 - BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB).METHODS: A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants.RESULTS: Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB.CONCLUSION: These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB.

AB - BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB).METHODS: A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants.RESULTS: Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB.CONCLUSION: These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB.

U2 - 10.5588/ijtld.22.0228

DO - 10.5588/ijtld.22.0228

M3 - Article

C2 - 35768923

SN - 1027-3719

VL - 26

SP - 592

EP - 604

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

IS - 7

ER -

Clinical standards for drug-susceptible pulmonary TB

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit